David H. Wang - Sep 12, 2023 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Signature
/s/ Mark McKechnie, Attorney-in-Fact for David H. Wang
Stock symbol
ACMR
Transactions as of
Sep 12, 2023
Transactions value $
-$3,130,016
Form type
4
Date filed
9/14/2023, 05:00 PM
Previous filing
Sep 6, 2023
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Sale -$1.56M -86.4K -12.73% $18.03 593K Sep 12, 2023 Direct F1, F2
transaction ACMR Class A Common Stock Sale -$66.9K -3.57K -0.6% $18.72 589K Sep 12, 2023 Direct F1, F3
transaction ACMR Class A Common Stock Sale -$1.5M -85.1K -14.45% $17.68 504K Sep 13, 2023 Direct F1, F4
holding ACMR Class A Common Stock 100K Sep 12, 2023 By Jing Chen, wife of David H. Wang
holding ACMR Class A Common Stock 45.8K Sep 12, 2023 By Sophia Wang, daughter of David H. Wang
holding ACMR Class A Common Stock 180K Sep 12, 2023 By David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children
holding ACMR Class A Common Stock 620K Sep 12, 2023 By Wang-Chen Family Living Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.64 to $18.79, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.12 to $18.05, inclusive.

Remarks:

Chief Executive Officer, President and Director